How to Tell If the Price Is Right on Your Next Prescription
CVS Health Profit Slides 17 Pct, Results Still Top Forecasts
How Do Insurers Decide What Medicines to Pay For?
CVS Generic Competitor to EpiPen, Sold at a 6th the Price
CVS is now selling a rival, generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to consumers. The drugstore chain says it will charge $109.99 for a two-pack of the authorized generic version…
Unhappy Target Customers Send Strong Message on Pill Bottles
Longtime customers of Target’s pharmacies are finding a change in pill bottle design hard to swallow. After CVS began operating Target’s drugstores earlier this year, distraught customers have been asking — in some cases begging — the drugstore chain to bring back the retailer’s red prescription bottles, which came with color-coded rings, labeling on the…
Mylan Launching Cheaper, Generic Version of EpiPen
Mylan will start selling a cheaper version of its EpiPen after absorbing waves of criticism over a list price for the emergency allergy treatment that has grown to $608 for a two-pack, making it unaffordable for many patients without insurance or with high-deductible coverage. The drugmaker says it will make available in the next several…
Mylan Boosts EpiPen Patient Programs, Doesn’t Budge on Price
Mylan is bulking up programs that help patients pay for its EpiPen emergency allergy treatment after weathering heated criticism about an average cost that has climbed more than 600 percent over the past decade. But the drugmaker didn’t budge on its price hikes Thursday, which have drawn ire both in Congress and from families that…